New dosing strategy aims to reduce side effects in schizophrenia treatment
NCT ID NCT06821945
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tests a new, slower way to increase the dose of olanzapine for people with schizophrenia. The goal is to see if this approach is safer and still controls symptoms effectively. About 120 adults with schizophrenia will take part, and researchers will monitor side effects and symptom changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hanyang University Guri Hospital
NOT_YET_RECRUITINGGuri-si, South Korea
Contact
-
Kyungbook National university hospital
RECRUITINGDaegu, South Korea
Contact
Conditions
Explore the condition pages connected to this study.